All Episodes

#73. The Triumph of Daraxonrasib

#72. 2026 Emerging Trends

#71. Magic Wands

#70. Beyond AlphaFold

#69. CollaboFest

#68. Molecular Glues in Therapy

#67. Does Size Matter?

#66. Quantitative Systems Pharmacology

#65. Orbiting around Big Pharma

#64. Foundation Models

#63. The Era of NAMs

#62. Predicting Toxicity

#61. AI Era Evidence Flywheel

#60. Cracking the "Undruggable" Target

#59. Drug Discovery AI Teammates

#58. Do We Need Mavericks?

#57. Do You Turst your AI?

#56. Ethics in AI for Drug Discovery

#55. AI for Drug Patents

#54. Companion Diagnostic Biomarkers

#53. The Math of AI Drug Discovery

#52. Benchmarking AI for Drug Discovery

#51. OpenClaw for BioPharma

#50. Atomic Level Drug Design

#49. From Prompts to Drugs

#48. Virtual Clinical Trials

#47. The Silicon Alchemist

#46. Top Ten AI Research Papers in 2025

#45. Genome-wide Virtual Screening

#44. Modern Drug Delivery Platforms

#43. Antibody-Drug Conjugate

#42. Biologic Immunogenecity

#41. CAR T Cell Therapy

#40. AI-Guided Alzheimer's Trial Design Lessons

#39. AI Drug Discovery Career Roadmap: Anti-Fragile Skills

#38. US and China Rivalry

#37. Open Source Drug Discovery 2.0

#36. Future of IND Filings

#35. AI-Driven Drug Repurposing

#34. AI Agents Transform Drug Discovery

#33. Modern Therapeutic Modalities

#32. AI Drug Discovery Startups

#31. Neuroendocrine Peptide Analogs

#30. Autism Data Science Initiative: Unlocking Precision Treatment

#29. Cystic Fibrosis: A Blueprint for Rare Disease Cures

#28. Eroom's Law

#27. Druggability and AI

#26. AI for Combination Drug Therapy

#25. Overall Survival Focus and AI Oncology Drugs

#24. Digital Twins: Transforming Clinical Trials

#23. AI and the Decentralization of Drug Discovery

#22. Molecular Glue Degraders

#21. N-of-1: the Future of Personalized Drug Development

#20. Ensifentrine's Triumph: An AI Blueprint for Drug Development

#19. AI Agents: Transforming Drug Discovery through Collaborative Partnerships

#18. First-in-Class vs. Best-in-Class AI Drug Discovery Strategies

#17. Atul Butte: Pioneer of Data-Driven Medicine

#16. Can AI scientists revolutionize drug discovery?

#15. AAV 2.0: Next-Generation Gene Therapy Vectors

#14. Global Trial & Error: Can AI Help? (05/30/2025)

#13. Chemical Space Docking: Is Bigger Better? (05/23/2025)

#12. Can AI help develop the next-generation diabetes drug? (05/16/2025)

#11. TYK2 Inhibitor Landscape and Pipeline (05/09/2025)

#10. Biomedical Research Funding and Innovation: May 2025 Senate Appropriation Committee Hearing (05/06/2025)

#9. Patent Dispute and Protections in the New AI Era (05/02/2025)

#8. Immune Response, Vaccines, and Autism: An Unbiased Scientific Review (04/25/2025)

#7. FDA Roadmap: Reducing Animal Testing in Preclinical Studies (04/22/2025)

#3. FDA Guidance: AI in Drug and Biological Product Regulatory Decisions (01/30/2025)

#2. 2024 Fierce 50: Innovations and Breakthroughs in Biopharma (01/01/2025)

#5. GLP-1 Medications: Current Status and Future Metabolic Therapies (03/15/2025)

#1. AI Drug Discovery in 2025: Trump, Kennedy, and Health Policy Outlook (11/14/2024)

#4. Alzheimer's Drug Development: Mechanisms, IP, and the Evolving Landscape (02/10/2025)

#6. AI in Drug Discovery - Reality Check (04/21/2025)